While we would not expect the major CLTCL1 polymorphism to directly influence the development of T2D, CHC22 accumulates on the expanded GSC that forms in cases of insulin-resistant T2D (Vassilopoulos et al., 2009), so its variation could potentially exacerbate insulin resistance to different degrees. The gene discussed is CLTCL1; the disease is Insulin resistance.